查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1509626

2024 年药物释放型支架全球市场报告

Drug Eluting Stent Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

药物释放型支架的市场规模预计在未来几年将强劲成长。 2028年将以8.4%的年复合成长率（CAGR）成长至105.2亿美元。预测期内的预期增长是由于人口老化和慢性病负担、适应症扩大、医疗报销政策、不断扩大的全球市场以及强调以患者为中心的护理等因素造成的。预测期内预计的主要趋势包括个人化医疗、微创技术、新兴医疗技术、下一代配方等。

心臟疾病负担的增加预计将推动药物释放型支架市场的未来扩张。当冠状动脉因斑块堆积而变窄或阻塞时，就会发生冠状动脉疾病（CHD），这可能会导致心臟病和胸痛等严重併发症。久坐的生活方式、不良的饮食习惯、人口老化和意识的提高正在导致心臟疾病的盛行率不断上升。药物释放型支架（DES）透过有效地扩张狭窄或闭塞的冠状动脉并释放药物以防止动脉血管再阻塞血管再阻塞（Masu），在心臟疾病的治疗中发挥重要作用。例如，根据美国疾病管制与预防中心的数据，18 岁及以上成年人的心臟疾病率将从 2020 年的 4.6% 增加到 2022 年的 4.9%。心臟疾病负担日益增加的趋势预计将推动药物释放型支架市场的成长。

药物释放型支架市场上的公司专注于开发创新的输送系统，例如双层球囊，以改善患者的治疗效果并推动介入性心臟病学。药物释放型支架系统中的双层球囊透过允许药物均匀地涂布和控製到动脉壁来提高药物输送和支架放置的精确度。例如，2022年8月，美敦力公司推出了Onyx，这是一种最新一代药物释放型冠状动脉支架系统，旨在增强输送系统，基于上一代Resolute Onyx DES的急性性能和临床资料，我们宣布了Frontier 。 Onyx Frontier DES 采用与 Resolute Onyx 相同的高品质支架平台，具有广泛的尺寸范围，可治疗直径从 2.0 毫米到 5.0 毫米的患者。显着的设计改进，包括创新的两层球囊、减少的横截面和增加的导管灵活性，与上一代 Resolute Onyx DES 相比，增加了输送能力，同时保持径向强度提高了 16%。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球药物释放型支架市场：驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球药物释放型支架市场表现：规模与成长，2018-2023
  • 全球药物释放型支架市场预测：规模与成长，2023-2028，2033F

第六章 市场细分

  • 全球药物释放型支架市场：按产品分類的绩效与预测，2018-2023、2023-2028F、2033F
  • 聚合物基
  • 不含聚合物
  • 全球药物释放型支架市场：依药物分類的表现与预测，2018-2023、2023-2028F、2033F
  • Sirolimus
  • 紫杉醇
  • 佐他莫司
  • Everolimus
  • 比奥莫司
  • 其他药品
  • 全球药物释放型支架市场：支架性能与预测，2018-2023、2023-2028F、2033F
  • 钴铬合金
  • 铂铬
  • 镍钛诺
  • 生物分解性
  • 其他脚手架
  • 全球药物释放型支架市场：按应用分類的表现和预测，2018-2023、2023-2028F、2033F
  • 冠状动脉疾病
  • 週边血管疾病
  • 全球药物释放型支架市场：最终用户的表现与预测，2018-2023、2023-2028F、2033F
  • 医院
  • 专科诊所

第 7 章 区域/国家分析

  • 全球药物释放型支架市场：按地区分類的绩效与预测，2018-2023、2023-2028F、2033F
  • 全球药物释放型支架市场：按国家/地区分類的绩效和预测，2018-2023、2023-2028F、2033F

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 药物释放型支架市场：竞争格局
  • 药物释放型支架市场：公司简介
    • Johnson & Johnson Services Inc.
    • Abbott
    • Medtronic plc
    • Boston Scientific Corporation
    • Terumo Corporation

第31章 其他大型创新企业

  • InspireMD Inc.
  • B. Braun Melsungen AG
  • Cook Group Incorporated
  • Lepu Medical Technology（Beijing）Co. Ltd.
  • Biotronik
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Biosensors International Group Ltd.
  • OrbusNeich Medical Company Limited
  • Alvimedica Medical Technologies
  • Hexacath
  • Elixir Medical Corporation
  • Translumina GmbH
  • Cardionovum GmbH
  • QualiMed Innovative Medizinprodukte GmbH

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章前瞻性与潜力分析

第36章附录

简介目录
Product Code: r18123

A drug-eluting stent (DES) is a medical device employed in the treatment of coronary artery disease (CAD). It constitutes a small, mesh-like tube typically constructed from metal, which is inserted into narrowed or blocked coronary arteries during a procedure known as percutaneous coronary intervention (PCI) or angioplasty.

The primary product types of drug-eluting stents include polymer-based and polymer-free varieties. Polymer-based drug-eluting stents (DES) are stents coated with a thin polymer layer that encapsulates the drug(s) intended for delivery to the arterial wall. These drugs may include sirolimus, paclitaxel, zotarolimus, everolimus, biolimus, among others, with scaffolds such as cobalt-chromium, platinum-chromium, nitinol, biodegradable materials, and others. They find application in coronary diseases and peripheral vascular disease and are utilized by end-users such as hospitals and specialty clinics.

The drug eluting stent market research report is one of a series of new reports from The Business Research Company that provides drug eluting stent market statistics, including drug eluting stent industry global market size, regional shares, competitors with a drug eluting stent market share, detailed drug eluting stent market segments, market trends and opportunities, and any further data you may need to thrive in the drug eluting stent industry. This drug eluting stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug eluting stent market size has grown strongly in recent years. It will grow from $7.05 billion in 2023 to $7.63 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The historical growth can be attributed to the necessity for enhanced treatment options, clinical evidence, regulatory approvals, healthcare economics, and guidelines and recommendations.

The drug eluting stent market size is expected to see strong growth in the next few years. It will grow to $10.52 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The anticipated growth in the forecast period can be attributed to factors such as an aging population and the burden of chronic diseases, expanded indications, healthcare reimbursement policies, global market expansion, and the emphasis on patient-centered care. Significant trends expected in the forecast period encompass personalized medicine, minimally invasive techniques, emerging healthcare technologies, and next-generation drug formulations.

The increasing burden of coronary heart disease is projected to drive the expansion of the drug-eluting stent market in the future. Coronary heart disease (CHD) occurs when the coronary arteries become narrowed or blocked due to plaque accumulation, potentially leading to severe complications such as heart attacks or chest pain. Sedentary lifestyles, poor dietary habits, aging populations, and heightened awareness contribute to the rising prevalence of coronary heart disease. Drug-eluting stents (DES) play a crucial role in managing coronary heart disease by effectively widening narrowed or blocked coronary arteries and releasing medication to prevent re-narrowing (restenosis) of the artery. For example, according to the Centers for Disease Control and Prevention, the percentage of adults aged 18 and over with coronary heart disease increased from 4.6% in 2020 to 4.9% in 2022. This upward trend in coronary heart disease burden is expected to fuel the growth of the drug-eluting stent market.

Companies operating in the drug-eluting stent market are directing their efforts toward developing innovative delivery systems, such as the dual-layer balloon, to enhance patient outcomes and advance interventional cardiology. A dual-layer balloon within a drug-eluting stent system improves precision in drug delivery and stent deployment by offering better control and uniform drug application to the arterial wall. For instance, in August 2022, Medtronic Plc introduced Onyx Frontier, the latest generation of drug-eluting coronary stent systems designed to enhance delivery systems, building upon the acute performance and clinical data from the previous Resolute Onyx DES generation. The Onyx Frontier DES utilizes the same high-quality stent platform as Resolute Onyx and features a wide size range to treat patients with diameters ranging from 2.0mm to 5.0mm. Notable design enhancements include a groundbreaking dual-layer balloon, reduced crossing profile, and enhanced catheter flexibility, resulting in a 16% increase in deliverability compared to the previous Resolute Onyx DES generation, while maintaining radial strength.

In October 2023, Cordis acquired MedAlliance for an undisclosed sum. This acquisition is aimed at furthering Cordis' tradition of cardiovascular innovation and expanding its product portfolio in the coronary and peripheral vascular markets. MedAlliance is a Switzerland-based medical device manufacturer and distributor specializing in drug-eluting stents.

Major companies operating in the drug eluting stent market are Johnson & Johnson Services Inc., Abbott, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, InspireMD Inc., B. Braun Melsungen AG, Cook Group Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Biotronik, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Company Limited, Alvimedica Medical Technologies, Hexacath, Elixir Medical Corporation, Translumina GmbH, Cardionovum GmbH, QualiMed Innovative Medizinprodukte GmbH, InSitu Technologies Inc., Acrostak AG, SINOMED Innovation Inc., Svelte Medical Systems Inc.

North America was the largest region in the drug-eluting stent market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug eluting stent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug eluting stent market consists of revenues earned by entities by providing services such as pre-procedural assessment, procedural intervention, intraoperative monitoring, post-procedural care, and patient education. The market value includes the value of related goods sold by the service provider or included within the service offering. The drug eluting stenting market also includes sales of products including guide wires, angioplasty equipment, intravascular imaging systems, hemostasis devices, and diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Eluting Stent Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug eluting stent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug eluting stent? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug eluting stent market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Polymer-Based; Polymer-Free
  • 2) By Drug: Sirolimus; Paclitaxel; Zotarolimus; Everolimus; Biolimus; Other Drugs
  • 3) By Scaffold: Cobalt-Chromium; Platinum-Chromium; Nitinol; Biodegradable; Other Scaffolds
  • 4) By Application: Coronary Diseases; Peripheral Vascular Diseases
  • 5) By End-User: Hospitals; Specialty Clinics
  • Companies Mentioned: Johnson & Johnson Services Inc.; Abbott; Medtronic plc; Boston Scientific Corporation; Terumo Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Eluting Stent Market Characteristics

3. Drug Eluting Stent Market Trends And Strategies

4. Drug Eluting Stent Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Drug Eluting Stent Market Size and Growth

  • 5.1. Global Drug Eluting Stent Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Drug Eluting Stent Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Drug Eluting Stent Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drug Eluting Stent Market Segmentation

  • 6.1. Global Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Polymer-Based
  • Polymer-Free
  • 6.2. Global Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Sirolimus
  • Paclitaxel
  • Zotarolimus
  • Everolimus
  • Biolimus
  • Other Drugs
  • 6.3. Global Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cobalt-Chromium
  • Platinum-Chromium
  • Nitinol
  • Biodegradable
  • Other Scaffold
  • 6.4. Global Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Coronary Diseases
  • Peripheral Vascular Diseases
  • 6.5. Global Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics

7. Drug Eluting Stent Market Regional And Country Analysis

  • 7.1. Global Drug Eluting Stent Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Drug Eluting Stent Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drug Eluting Stent Market

  • 8.1. Asia-Pacific Drug Eluting Stent Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drug Eluting Stent Market

  • 9.1. China Drug Eluting Stent Market Overview
  • 9.2. China Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drug Eluting Stent Market

  • 10.1. India Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drug Eluting Stent Market

  • 11.1. Japan Drug Eluting Stent Market Overview
  • 11.2. Japan Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drug Eluting Stent Market

  • 12.1. Australia Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drug Eluting Stent Market

  • 13.1. Indonesia Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drug Eluting Stent Market

  • 14.1. South Korea Drug Eluting Stent Market Overview
  • 14.2. South Korea Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drug Eluting Stent Market

  • 15.1. Western Europe Drug Eluting Stent Market Overview
  • 15.2. Western Europe Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drug Eluting Stent Market

  • 16.1. UK Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drug Eluting Stent Market

  • 17.1. Germany Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drug Eluting Stent Market

  • 18.1. France Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drug Eluting Stent Market

  • 19.1. Italy Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drug Eluting Stent Market

  • 20.1. Spain Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drug Eluting Stent Market

  • 21.1. Eastern Europe Drug Eluting Stent Market Overview
  • 21.2. Eastern Europe Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drug Eluting Stent Market

  • 22.1. Russia Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drug Eluting Stent Market

  • 23.1. North America Drug Eluting Stent Market Overview
  • 23.2. North America Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drug Eluting Stent Market

  • 24.1. USA Drug Eluting Stent Market Overview
  • 24.2. USA Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drug Eluting Stent Market

  • 25.1. Canada Drug Eluting Stent Market Overview
  • 25.2. Canada Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drug Eluting Stent Market

  • 26.1. South America Drug Eluting Stent Market Overview
  • 26.2. South America Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drug Eluting Stent Market

  • 27.1. Brazil Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drug Eluting Stent Market

  • 28.1. Middle East Drug Eluting Stent Market Overview
  • 28.2. Middle East Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drug Eluting Stent Market

  • 29.1. Africa Drug Eluting Stent Market Overview
  • 29.2. Africa Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drug Eluting Stent Market Competitive Landscape And Company Profiles

  • 30.1. Drug Eluting Stent Market Competitive Landscape
  • 30.2. Drug Eluting Stent Market Company Profiles
    • 30.2.1. Johnson & Johnson Services Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Medtronic plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Boston Scientific Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Terumo Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Drug Eluting Stent Market Other Major And Innovative Companies

  • 31.1. InspireMD Inc.
  • 31.2. B. Braun Melsungen AG
  • 31.3. Cook Group Incorporated
  • 31.4. Lepu Medical Technology (Beijing) Co. Ltd.
  • 31.5. Biotronik
  • 31.6. Meril Life Sciences Pvt. Ltd.
  • 31.7. MicroPort Scientific Corporation
  • 31.8. Biosensors International Group Ltd.
  • 31.9. OrbusNeich Medical Company Limited
  • 31.10. Alvimedica Medical Technologies
  • 31.11. Hexacath
  • 31.12. Elixir Medical Corporation
  • 31.13. Translumina GmbH
  • 31.14. Cardionovum GmbH
  • 31.15. QualiMed Innovative Medizinprodukte GmbH

32. Global Drug Eluting Stent Market Competitive Benchmarking

33. Global Drug Eluting Stent Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Drug Eluting Stent Market

35. Drug Eluting Stent Market Future Outlook and Potential Analysis

  • 35.1 Drug Eluting Stent Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Drug Eluting Stent Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Drug Eluting Stent Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer